Loading…
Reported covered position: Intern, Sen. Barack Obama
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Transparency in All Health Care Pricing Act of 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1409, Cancer Drug Coverage Parity Act
Access to Breast Cancer Diagnosis Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 2428, S 3216 ABCD Act Implementation of Affordable Care Act Surprise Medical Billing Public and private insurance and other policy changes due to the COVID emergency
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2020 · first_quarter · 1T
Hematology research, prevention and public health programs Sickle Cell Disease Surveillance, HRSA Demonstration program on Sickle Cell disease FY2021 Labor HHS Appropriations
HR 1409, Cancer Drug Coverage Parity Act
Source: Senate LDA
| ADULT CONGENITAL HEART ASSOCIATION |
| 16 |
| 2015–2018 |
| AMERICAN BRAIN COALITION | 15 | 2012–2015 |
| ALPHA-1 FOUNDATION | 14 | 2015–2018 |
| GAY MEN'S HEALTH CRISIS | 12 | 2011–2012 |
| SOCIETY FOR MATERNAL-FETAL MEDICINE | 5 | 2019–2020 |
| AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS | 4 | 2019–2020 |
| NATIONAL COALITION FOR OSTEOPOROSIS AND RELATED BONE DISEASES | 4 | 2011 |
| JOHNS HOPKINS UNIVERSITY MOORE CENTER FOR THE PREVENTION OF CHILD SEXUAL ABUSE | 2 | 2019 |
| WOMEN FIRST RESEARCH COALITION | 1 | 2020 |
Access to Breast Cancer Diagnosis Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 2428, S 3216 ABCD Act Implementation of Affordable Care Act Surprise Medical Billing Public and private insurance and other policy changes due to the COVID emergency
Access to Breast Cancer Diagnosis Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 2428, S 3216 ABCD Act Implementation of Affordable Care Act Surprise Medical Billing Public and private insurance and other policy changes due to the COVID emergency
Elijah E. Cummings Lower Drug Costs Now Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act S 1895, Lower Healthcare Cost Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Drug Pricing Issues S.3233/HR5952 Hemophilia SNF Access ActS.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare, Medicaid and other policy changes due to the COVID emergency
Elijah E. Cummings Lower Drug Costs Now Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients S.3233/HR5952 Hemophilia SNF Access Act. Medicare, Medicaid and other policy changes due to the COVID emergency. Medicare Coverage and Reimbursement of drugs Medicaid coverage policy S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Surprise medical billing
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 language on Medicare, Medicaid and other policy changes due to the COVID emergency.
Protecting People From Surprise Medical Bills Act
Client: AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
S2586 Maternal Outcomes Matter Act of 2019 S1895 Lower Health Care Costs Act HR 3630 No Surprises Act HR 3502 Protecting People from Surprise Medical Bills Act Maternity Mortality Legislation HR 4995 Maternal Health Quality Improvement Act of 2019 Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) NIH women's health research funding
No Surprises Act
Client: AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
S2586 Maternal Outcomes Matter Act of 2019 S1895 Lower Health Care Costs Act HR 3630 No Surprises Act HR 3502 Protecting People from Surprise Medical Bills Act Maternity Mortality Legislation HR 4995 Maternal Health Quality Improvement Act of 2019 Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) NIH women's health research funding
Maternal Health Quality Improvement Act of 2020
Client: AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
S2586 Maternal Outcomes Matter Act of 2019 S1895 Lower Health Care Costs Act HR 3630 No Surprises Act HR 3502 Protecting People from Surprise Medical Bills Act Maternity Mortality Legislation HR 4995 Maternal Health Quality Improvement Act of 2019 Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) NIH women's health research funding
Helping Medicaid Offer Maternity Services Act of 2020
Client: AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
CY 2020 Physician Fee Schedule E/M global period policy HR 4996 Helping Medicaid Offer Maternity Services Act of 2019
Hemophilia SNF Access Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Drug Pricing Issues S.3233/HR5952 Hemophilia SNF Access ActS.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare, Medicaid and other policy changes due to the COVID emergency
Hemophilia SNF Access Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients S.3233/HR5952 Hemophilia SNF Access Act. Medicare, Medicaid and other policy changes due to the COVID emergency. Medicare Coverage and Reimbursement of drugs Medicaid coverage policy S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Surprise medical billing
Lower Health Care Costs Act
Client: AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
S2586 Maternal Outcomes Matter Act of 2019 S1895 Lower Health Care Costs Act HR 3630 No Surprises Act HR 3502 Protecting People from Surprise Medical Bills Act Maternity Mortality Legislation HR 4995 Maternal Health Quality Improvement Act of 2019 Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) NIH women's health research funding
Lower Health Care Costs Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Lower Health Care Costs Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act S 1895, Lower Healthcare Cost Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients S.3233/HR5952 Hemophilia SNF Access Act. Medicare, Medicaid and other policy changes due to the COVID emergency. Medicare Coverage and Reimbursement of drugs Medicaid coverage policy S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Surprise medical billing
Prescription Drug Pricing Reduction Act of 2019
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act S 1895, Lower Healthcare Cost Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 language on Medicare, Medicaid and other policy changes due to the COVID emergency.
Prescription Drug Pricing Reduction Act of 2019
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
MOM Act
Client: AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
S2586 Maternal Outcomes Matter Act of 2019 S1895 Lower Health Care Costs Act HR 3630 No Surprises Act HR 3502 Protecting People from Surprise Medical Bills Act Maternity Mortality Legislation HR 4995 Maternal Health Quality Improvement Act of 2019 Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) NIH women's health research funding
Access to Breast Cancer Diagnosis Act of 2020
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 2428, S 3216 ABCD Act Implementation of Affordable Care Act Surprise Medical Billing Public and private insurance and other policy changes due to the COVID emergency
Access to Breast Cancer Diagnosis Act of 2020
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 2428, S 3216 ABCD Act Implementation of Affordable Care Act Surprise Medical Billing Public and private insurance and other policy changes due to the COVID emergency
Access to Breast Cancer Diagnosis Act of 2020
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 2428, S 3216 ABCD Act Implementation of Affordable Care Act Surprise Medical Billing Public and private insurance and other policy changes due to the COVID emergency
Hemophilia SNF Access Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Drug Pricing Issues S.3233/HR5952 Hemophilia SNF Access ActS.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare, Medicaid and other policy changes due to the COVID emergency
Hemophilia SNF Access Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients S.3233/HR5952 Hemophilia SNF Access Act. Medicare, Medicaid and other policy changes due to the COVID emergency. Medicare Coverage and Reimbursement of drugs Medicaid coverage policy S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Surprise medical billing
To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect.
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010
To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect.
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lover Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act
To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect.
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1895, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors
To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect.
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1895, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors Implementation of Affordable Care Act; Public Change; SJ Res 52 S 2543 Prescription Drug Price Relief Act HR 3 Lower Drug Costs Now Act of 2019
To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect.
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1985, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors
To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect.
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lower Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 SJ Res 52; Public Charge
ENROLL Act of 2019
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lover Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act
ENROLL Act of 2019
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lower Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 SJ Res 52; Public Charge
ENROLL Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1895, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors
ENROLL Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1985, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors
ENROLL Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1895, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors Implementation of Affordable Care Act; Public Change; SJ Res 52 S 2543 Prescription Drug Price Relief Act HR 3 Lower Drug Costs Now Act of 2019
Transparency in All Health Care Pricing Act of 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1409, Cancer Drug Coverage Parity Act
Transparency in All Health Care Pricing Act of 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1409, Cancer Drug Coverage Parity Act
Transparency in All Health Care Pricing Act of 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1409, Cancer Drug Coverage Parity Act
Transparency in All Health Care Pricing Act of 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1409, Cancer Drug Coverage Parity Act
Cancer Drug Parity Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1895, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors Implementation of Affordable Care Act; Public Change; SJ Res 52 S 2543 Prescription Drug Price Relief Act HR 3 Lower Drug Costs Now Act of 2019
Cancer Drug Parity Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act Diagnostic imaging for breast cancer patients and survivors
Cancer Drug Parity Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1895, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors
Cancer Drug Parity Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1985, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors
Protecting Pre-Existing Conditions and Making Health Care More Affordable Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1895, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors
Protecting Pre-Existing Conditions and Making Health Care More Affordable Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1895, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors Implementation of Affordable Care Act; Public Change; SJ Res 52 S 2543 Prescription Drug Price Relief Act HR 3 Lower Drug Costs Now Act of 2019
Protecting Pre-Existing Conditions and Making Health Care More Affordable Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1985, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors
Access to Breast Cancer Diagnosis Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1895, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors Implementation of Affordable Care Act; Public Change; SJ Res 52 S 2543 Prescription Drug Price Relief Act HR 3 Lower Drug Costs Now Act of 2019
Access to Breast Cancer Diagnosis Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1895, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors
Access to Breast Cancer Diagnosis Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1985, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors
Access to Breast Cancer Diagnosis Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 2428, ABCD Act S 1895, Lower Health Care Costs Act Implementation of Affordable Care Act S 2543 Prescription Drug Price Relief Act HR 3 Lower Drug Costs Now Act of 2019 Surprise Medical Billing
Stronger Child Abuse Prevention and Treatment Act
Client: JOHNS HOPKINS UNIVERSITY MOORE CENTER FOR THE PREVENTION OF CHILD SEXUAL ABUSE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Child Welfare, Social Services HR 2480 Stronger Child Abuse Prevention & Treatment Act
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare Physician Fee Schedule for 2020 Proposed Rule
Elijah E. Cummings Lower Drug Costs Now Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act S 1895, Lower Healthcare Cost Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients Medicare Reimbursement of SNF services Medicare Coverage and Reimbursement of drugs Medicaid coverage policy S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Surprise medical billing
Elijah E. Cummings Lower Drug Costs Now Act
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 2428, ABCD Act S 1895, Lower Health Care Costs Act Implementation of Affordable Care Act S 2543 Prescription Drug Price Relief Act HR 3 Lower Drug Costs Now Act of 2019 Surprise Medical Billing
Elijah E. Cummings Lower Drug Costs Now Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Drug Pricing Issues Medicare Reimbursement of SNF Services S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients Medicare Reimbursement of SNF services Medicare Coverage and Reimbursement of drugs Medicaid coverage policy S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lower Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 SJ Res 52; Public Charge
Elijah E. Cummings Lower Drug Costs Now Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1895, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors Implementation of Affordable Care Act; Public Change; SJ Res 52 S 2543 Prescription Drug Price Relief Act HR 3 Lower Drug Costs Now Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Drug Pricing Issues Medicare Reimbursement of SNF Services S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare Physician Fee Schedule for 2020 Proposed Rule
Protecting People From Surprise Medical Bills Act
Client: AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
S2586 Maternal Outcomes Matter Act of 2019 S1895 Lower Health Care Costs Act HR 3630 No Surprises Act HR 3502 Protecting People from Surprise Medical Bills Act Maternity Mortality Legislation Cures 2.0 FDA review of Supplemental new drug application for Makena
Protecting People From Surprise Medical Bills Act
Client: AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
S2586 Maternal Outcomes Matter Act of 2019 S1895 Lower Health Care Costs Act HR 3630 No Surprises Act HR 3502 Protecting People from Surprise Medical Bills Act Maternity Mortality Legislation Cures 2.0 FDA review of Supplemental new drug application for Makena HR 4995 Maternal Health Quality Improvement Act of 2019
No Surprises Act
Client: AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
S2586 Maternal Outcomes Matter Act of 2019 S1895 Lower Health Care Costs Act HR 3630 No Surprises Act HR 3502 Protecting People from Surprise Medical Bills Act Maternity Mortality Legislation Cures 2.0 FDA review of Supplemental new drug application for Makena HR 4995 Maternal Health Quality Improvement Act of 2019
No Surprises Act
Client: AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
S2586 Maternal Outcomes Matter Act of 2019 S1895 Lower Health Care Costs Act HR 3630 No Surprises Act HR 3502 Protecting People from Surprise Medical Bills Act Maternity Mortality Legislation Cures 2.0 FDA review of Supplemental new drug application for Makena
Maternal Health Quality Improvement Act of 2020
Client: AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
S2586 Maternal Outcomes Matter Act of 2019 S1895 Lower Health Care Costs Act HR 3630 No Surprises Act HR 3502 Protecting People from Surprise Medical Bills Act Maternity Mortality Legislation Cures 2.0 FDA review of Supplemental new drug application for Makena HR 4995 Maternal Health Quality Improvement Act of 2019
Helping Medicaid Offer Maternity Services Act of 2020
Client: AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
CY 2020 Physician Fee Schedule E/M global period policy HR 4996 Helping Medicaid Offer Maternity Services Act of 2019
Protecting Americans with Preexisting Conditions Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1895, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors Implementation of Affordable Care Act; Public Change; SJ Res 52 S 2543 Prescription Drug Price Relief Act HR 3 Lower Drug Costs Now Act of 2019
Protecting Americans with Preexisting Conditions Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1985, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors
Protecting Americans with Preexisting Conditions Act of 2019
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lover Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act
Protecting Americans with Preexisting Conditions Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1895, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors
Protecting Americans with Preexisting Conditions Act of 2019
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lower Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 SJ Res 52; Public Charge
Strengthening Health Care and Lowering Prescription Drug Costs Act
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1895, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors
Strengthening Health Care and Lowering Prescription Drug Costs Act
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1895, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors Implementation of Affordable Care Act; Public Change; SJ Res 52 S 2543 Prescription Drug Price Relief Act HR 3 Lower Drug Costs Now Act of 2019
Strengthening Health Care and Lowering Prescription Drug Costs Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lower Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 SJ Res 52; Public Charge
Strengthening Health Care and Lowering Prescription Drug Costs Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lover Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act
Strengthening Health Care and Lowering Prescription Drug Costs Act
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1985, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors
Lower Health Care Costs Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act
Lower Health Care Costs Act
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 2428, ABCD Act S 1895, Lower Health Care Costs Act Implementation of Affordable Care Act S 2543 Prescription Drug Price Relief Act HR 3 Lower Drug Costs Now Act of 2019 Surprise Medical Billing
Lower Health Care Costs Act
Client: AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
S2586 Maternal Outcomes Matter Act of 2019 S1895 Lower Health Care Costs Act HR 3630 No Surprises Act HR 3502 Protecting People from Surprise Medical Bills Act Maternity Mortality Legislation Cures 2.0 FDA review of Supplemental new drug application for Makena HR 4995 Maternal Health Quality Improvement Act of 2019
Lower Health Care Costs Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Lower Health Care Costs Act
Client: AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Maternal health and mortality; S. 1895 the Lower Health Costs Act; Surprise Medical Billing; access to health care; revisions to Public Law 114-10 the Medicare Access and CHIP Reauthorization Act; Surprise Medical billing; Medicaid coverage
Lower Health Care Costs Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act S 1895, Lower Healthcare Cost Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Lower Health Care Costs Act
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1895, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors Implementation of Affordable Care Act; Public Change; SJ Res 52 S 2543 Prescription Drug Price Relief Act HR 3 Lower Drug Costs Now Act of 2019
Lower Health Care Costs Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Lower Health Care Costs Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lover Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act
Lower Health Care Costs Act
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1895, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors
Lower Health Care Costs Act
Client: AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
S2586 Maternal Outcomes Matter Act of 2019 S1895 Lower Health Care Costs Act HR 3630 No Surprises Act HR 3502 Protecting People from Surprise Medical Bills Act Maternity Mortality Legislation Cures 2.0 FDA review of Supplemental new drug application for Makena
Lower Health Care Costs Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lower Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 SJ Res 52; Public Charge
Lower Health Care Costs Act
Client: AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Maternal health and mortality; S. 1895 the Lower Health Costs Act; Surprise Medical Billing; access to health care; revisions to Public Law 114-10 the Medicare Access and CHIP Reauthorization Act; Surprise Medical billing; Medicaid coverage
STRANDED Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1985, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors
Prescription Drug Pricing Reduction Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1895, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors Implementation of Affordable Care Act; Public Change; SJ Res 52 S 2543 Prescription Drug Price Relief Act HR 3 Lower Drug Costs Now Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 2428, ABCD Act S 1895, Lower Health Care Costs Act Implementation of Affordable Care Act S 2543 Prescription Drug Price Relief Act HR 3 Lower Drug Costs Now Act of 2019 Surprise Medical Billing
Prescription Drug Pricing Reduction Act of 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare Physician Fee Schedule for 2020 Proposed Rule
Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 language on Medicare, Medicaid and other policy changes due to the COVID emergency.
Research in hematology
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2020 · first_quarter · Q1
S2586 Maternal Outcomes Matter Act of 2019 S1895 Lower Health Care Costs Act HR 3630 No Surprises Act HR 3502 Protecting People from Surprise Medical Bills Act Maternity Mortality Legislation HR 4995 Maternal Health Quality Improvement Act of 2019 Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) NIH women's health research funding
CY 2020 Physician Fee Schedule E/M global period policy HR 4996 Helping Medicaid Offer Maternity Services Act of 2019
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
SOCIETY FOR MATERNAL-FETAL MEDICINE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2020 · first_quarter · 1T
Issues related to the Task Force on Research specific to Pregnant Women and Lactating Women (PRGLAC)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2020 · first_quarter · 1@
Medicare Coverage policies for drugs; drug pricing; Medicaid coverage policy Medicare, Medicaid and other policy changes due to the COVID emergency
FY21 National Defense Authorization Act - CDMRP
HR 2428, S 3216 ABCD Act Implementation of Affordable Care Act Surprise Medical Billing Public and private insurance and other policy changes due to the COVID emergency
FY2021, Labor, HHS and Education Appropriations bill Funding for DOD breast cancer research program
nonprofit relief provisions of COVID-related legislation
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2020 · first_quarter · Q1
HR 2428, S 3216 ABCD Act Implementation of Affordable Care Act Surprise Medical Billing Public and private insurance and other policy changes due to the COVID emergency
FY2021, Labor, HHS and Education Appropriations bill Funding for DOD breast cancer research program
FY21 National Defense Authorization Act - CDMRP
nonprofit relief provisions of COVID-related legislation
Medicare Coverage policies for drugs; drug pricing; Medicaid coverage policy Medicare, Medicaid and other policy changes due to the COVID emergency
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2020 · first_quarter · 1T
Medicare Coverage policies for drugs; drug pricing; Medicaid coverage policy Medicare, Medicaid and other policy changes due to the COVID emergency
FY21 National Defense Authorization Act - CDMRP
HR 2428, S 3216 ABCD Act Implementation of Affordable Care Act Surprise Medical Billing Public and private insurance and other policy changes due to the COVID emergency
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2020 · first_quarter · 1T
Research and public health programs in epilepsy.
Healthcare issues related to the treatment of epilepsy.
Issues related to anti-epileptic drugs.
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2020 · first_quarter · 1T
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
Funding for Hemophilia program FY 2020 Labor, HHS and Education Appropriations
Implementation of the Affordable Care Act S 1895, Lower Healthcare Cost Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2020 · first_quarter · 1T
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Issues related to the 340B drug discount program and drug pricing policies
Hemophilia program funding
WOMEN FIRST RESEARCH COALITION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2020 · first_quarter · RR
NIH and women's health research and funding
NIH and women's health research and funding
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · fourth_quarter · Q4
Research and public health programs in epilepsy.
Issues related to anti-epileptic drugs.
Funding for epilepsy programs at CDC, HRSA, NIH
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · fourth_quarter · Q4
Hemophilia research, prevention, surveillance and service programs and issues
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients Medicare Reimbursement of SNF services Medicare Coverage and Reimbursement of drugs Medicaid coverage policy S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Surprise medical billing
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · fourth_quarter · Q4
Hemophilia program funding
Issues related to the 340B drug discount program and drug pricing policies
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Drug Pricing Issues Medicare Reimbursement of SNF Services S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · fourth_quarter · Q4
Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare Physician Fee Schedule for 2020 Proposed Rule
Hematology research, prevention and public health programs Sickle Cell Disease Surveillance, HRSA Demonstration program on Sickle Cell disease FY2020 Labor HHS Appropriations
HR 1409, Cancer Drug Coverage Parity Act
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · fourth_quarter · Q4
Medicare Coverage policies for drugs; drug pricing; Medicaid coverage policy
HR 2428, ABCD Act S 1895, Lower Health Care Costs Act Implementation of Affordable Care Act S 2543 Prescription Drug Price Relief Act HR 3 Lower Drug Costs Now Act of 2019 Surprise Medical Billing
FY2020, Labor, HHS and Education Appropriations bill Funding for DOD breast cancer research program
JOHNS HOPKINS UNIVERSITY MOORE CENTER FOR THE PREVENTION OF CHILD SEXUAL ABUSE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · fourth_quarter · Q4
FY2020 Funding for Child Sexual Abuse Prevention at the Department of HHS
Child Welfare, Social Services HR 2480 Stronger Child Abuse Prevention & Treatment Act
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SOCIETY FOR MATERNAL-FETAL MEDICINE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · fourth_quarter · Q4
Issues related to the Task Force on Research specific to Pregnant Women and Lactating Women (PRGLAC)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · fourth_quarter · Q4
S2586 Maternal Outcomes Matter Act of 2019 S1895 Lower Health Care Costs Act HR 3630 No Surprises Act HR 3502 Protecting People from Surprise Medical Bills Act Maternity Mortality Legislation Cures 2.0 FDA review of Supplemental new drug application for Makena HR 4995 Maternal Health Quality Improvement Act of 2019
CY 2020 Physician Fee Schedule E/M global period policy HR 4996 Helping Medicaid Offer Maternity Services Act of 2019
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · third_quarter · Q3
CY 2020 Physician Fee Schedule E/M global period policy
S2586 Maternal Outcomes Matter Act of 2019 S1895 Lower Health Care Costs Act HR 3630 No Surprises Act HR 3502 Protecting People from Surprise Medical Bills Act Maternity Mortality Legislation Cures 2.0 FDA review of Supplemental new drug application for Makena
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
FY2020 Funding for Child Sexual Abuse Prevention at the Department of HHS
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SOCIETY FOR MATERNAL-FETAL MEDICINE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · third_quarter · Q3
Issues related to the Task Force on Research specific to Pregnant Women and Lactating Women (PRGLAC)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · third_quarter · Q3
FY2020, Labor, HHS and Education Appropriations bill Funding for DOD breast cancer research program
Medicare Coverage policies for drugs; drug pricing; Medicaid coverage policy
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1895, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors Implementation of Affordable Care Act; Public Change; SJ Res 52 S 2543 Prescription Drug Price Relief Act HR 3 Lower Drug Costs Now Act of 2019
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · third_quarter · Q3
Issues related to anti-epileptic drugs.
Implementation of the Affordable Care Act
Healthcare issues related to the treatment of epilepsy.
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · third_quarter · Q3
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Drug Pricing Issues Medicare Reimbursement of SNF Services S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Hemophilia program funding
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · third_quarter · Q3
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients Medicare Reimbursement of SNF services Medicare Coverage and Reimbursement of drugs Medicaid coverage policy S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
Hemophilia research, prevention, surveillance and service programs and issues
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · third_quarter · Q3
Research in hematology
HR 1409, Cancer Drug Coverage Parity Act
Hematology research, prevention and public health programs Sickle Cell Disease Surveillance, HRSA Demonstration program on Sickle Cell disease FY2020 Labor HHS Appropriations
AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · third_quarter · RR
Maternal health and mortality; S. 1895 the Lower Health Costs Act; Surprise Medical Billing; access to health care; revisions to Public Law 114-10 the Medicare Access and CHIP Reauthorization Act; Surprise Medical billing; Medicaid coverage
Maternal health and mortality; S. 1895 the Lower Health Costs Act; Surprise Medical Billing; access to health care; revisions to Public Law 114-10 the Medicare Access and CHIP Reauthorization Act; Surprise Medical billing; Medicaid coverage
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · second_quarter · Q2
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act
Issues related to the 340B drug discount program and drug pricing policies
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Drug Pricing Issues Medicare Reimbursement of SNF Services
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · second_quarter · Q2
Research in hematology
Hematology research, prevention and public health programs Sickle Cell Disease Surveillance, HRSA Demonstration program on Sickle Cell disease FY2020 Labor HHS Appropriations
HR 1409, Cancer Drug Coverage Parity Act
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · second_quarter · Q2
Healthcare issues related to the treatment of epilepsy.
Funding for epilepsy programs at CDC, HRSA, NIH
Issues related to anti-epileptic drugs.
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · second_quarter · 2A
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1895, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors
Medicare Coverage policies for drugs
FY2020, Labor, HHS and Education Appropriations bill Funding for DOD breast cancer research program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · second_quarter · Q2
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
Funding for Hemophilia program FY 2020 Labor, HHS and Education Appropriations
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients Medicare Reimbursement of SNF services Medicare Coverage and Reimbursement of drugs
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · second_quarter · Q2
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1985, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors
FY2020, Labor, HHS and Education Appropriations bill Funding for DOD breast cancer research program
Medicare Coverage policies for drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY FOR MATERNAL-FETAL MEDICINE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · second_quarter · Q2
Issues related to the Task Force on Research specific to Pregnant Women and Lactating Women (PRGLAC)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY FOR MATERNAL-FETAL MEDICINE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · second_quarter · RA
represent the Society for Maternal-Fetal Medicine to assist with the Coalition to Advance Maternal Therapeutics regarding implementation of the recommendations of the Task Force on Research specific to pregnant women and lactating women.
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · first_quarter · 1A
HR 1730/S 741 Cancer Drug Parity Act Diagnostic imaging for breast cancer patients and survivors
FY2020, Labor, HHS and Education Appropriations bill Funding for DOD breast cancer research program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · first_quarter · Q1
Funding for Hemophilia program FY 2020 Labor, HHS and Education Appropriations
Implementation of the Affordable Care Act HR 1010
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · first_quarter · Q1
FY202, Labor, HHS and Education Appropriations bill Funding for DOD breast cancer research program
HR 1409 Cancer Drug Parity Act of 2017 Diagnostic imaging for breast cancer patients plus survivors
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · first_quarter · Q1
Issues related to anti-epileptic drugs.
Healthcare issues related to the treatment of epilepsy.
Implementation of the Affordable Care Act
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · first_quarter · Q1
Hemophilia program funding
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Medicare Hospital Outpatient PPS Proposed Rule Drug Pricing Issues Medicare Reimbursement of SNF Services
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · first_quarter · Q1
Hematology research, prevention and public health programs Sickle Cell Disease Surveillance, HRSA Demonstration program on Sickle Cell disease FY2020 Labor HHS Appropriations
HR 1409, Cancer Drug Coverage Parity Act
Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · fourth_quarter · Q4
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410/S 2465 SCD Research, Surveillance Prevention and Treatment Act of 2017
Hematology research, prevention and public health programs Sickle Cell Disease Surveillance
Medicare reimbursement for physician, and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · fourth_quarter · Q4
Hemophilia research, prevention, surveillance and service programs and issues.
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
Implementation of the Affordable Care Act S. 3388 - Ensuring Coverage for People with Pre-Existing Conditions Act
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · fourth_quarter · Q4
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug reimbursement Medicare Hospital Outpatient PPS proposed Rule International Drug Pricing Rule
Issues related to the 340B drug discount program and drug pricing policies
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · fourth_quarter · Q4
Issues related to anti-epileptic drugs.
Implementation of the Affordable Care Act
Funding for epilepsy programs at CDC, HRSA, NIH
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · fourth_quarter · Q4
FY 2019 Labor, Health and Human Services and Education Appropriations bill
H.R. 1409 Cancer Drug Parity Act of 2017 H.R. 4978 Chronic Disease Management Act of 2018 S. 3388 Ensuring Coverage for Patients with Pre-Existing Conditions Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADULT CONGENITAL HEART ASSOCIATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · fourth_quarter · Q4
Congenital Heart Futures Act Reauthorization; HR 1222, S 477 Patient Access to Care
Funding for NIH and the CDC Congenital Heart Disease program
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · third_quarter · Q3
HR 1017, Removing Barriers to Colorectal Cancer Screening Act Clinical Trial Policy
FY 2019 Labor, Health and Human Services and Education Appropriations bill
H.R. 1409 Cancer Drug Parity Act of 2017 H.R. 4978 Chronic Disease Management Act of 2018 S. 3388 Ensuring Coverage for Patients with Pre-Existing Conditions Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · third_quarter · Q3
Hemophilia research, prevention, surveillance and service programs and issues.
reimbursement for hemophilia services and treatments; Medicaid reimbursement for treatments for hemophilia patients
Implementation of the Affordable Care Act S. 3388 - Ensuring Coverage for People with Pre-Existing Conditions Act
ALPHA-1 FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · third_quarter · 3T
FDA drug development and clinical trials; Precision Medicine Initiative; Patient Access to Care; Drug Pricing
FY19 Labor-HHS Appropriations - House Subcommittee Draft/S.3158
CMS coverage policies - re: oxygen, Medicare reimbursement
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
ADULT CONGENITAL HEART ASSOCIATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · third_quarter · Q3
Congenital Heart Futures Act Reauthorization; HR 1222, S 477 Patient Access to Care
H.R. 6157 - Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · third_quarter · Q3
Research and public health programs in epilepsy.
Implementation of the Affordable Care Act
Issues related to anti-epileptic drugs.
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · third_quarter · Q3
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug reimbursement Medicare Hospital Outpatient PPS proposed Rule
Issues related to the 340B drug discount program and drug pricing policies
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · third_quarter · Q3
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410/S 2465 SCD Research, Surveillance Prevention and Treatment Act of 2017
Medicare reimbursement for physician, and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule
HR 6157 - Department of Defense, Labor and HHS Appropriations Act, 2019 Hematology research, prevention and public health programs Sickle Cell Disease Surveillance
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · second_quarter · Q2
Labor-HHS-Appropriations Act for FY 2019 Funding for Hemophilia programs
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
Hemophilia research, prevention, surveillance and service programs and issues.
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · second_quarter · Q2
Research and public health programs in epilepsy.
Issues related to anti-epileptic drugs.
Funding for epilepsy programs at CDC, HRSA, NIH
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · second_quarter · Q2
Labor-HHS-Education Appropriations Act 2019 Hemophilia program funding
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug reimbursement
Issues related to the 340B drug discount program
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · second_quarter · Q2
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410/S 2465 SCD Research, Surveillance Prevention and Treatment Act of 2017
Medicare reimbursement for physician, and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule
HR 1409, Cancer Drug Coverage Parity Act
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · second_quarter · Q2
HR 1017, Removing Barriers to Colorectal Cancer Screening Act Clinical Trial Policy
FY 2019 Labor, Health and Human Services and Education Appropriations bill
H.R. 1409 Cancer Drug Parity Act of 2017 H.R. 4978 Chronic Disease Management Act of 2018
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALPHA-1 FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · second_quarter · Q2
CMS coverage policies - re: oxygen, Medicare reimbursement
FDA drug development and clinical trials; Precision Medicine Initiative; Patient Access to Care; Drug Pricing
FY19 Labor-HHS Appropriations - House Subcommittee Draft/S.3158
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
ADULT CONGENITAL HEART ASSOCIATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · second_quarter · Q2
FY19 Labor-HHS Appropriations - House Subcommittee Draft/ S.3158
Congenital Heart Futures Act Reauthorization; HR 1222, S 477 Patient Access to Care
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · first_quarter · Q1
Issues related to the 340B drug discount program
Issues related to reimbursement for hemophilia services and treatments. Medicaid Outpatient Drug Rule; Medicare Part B Drug reimbursement
Implementation of the Affordable Care Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · first_quarter · Q1
Hemophilia research, prevention, surveillance and service programs and issues.
Implementation of the Affordable Care Act
reimbursement for hemophilia services and treatments; Medicaid reimbursement for treatments for hemophilia patients
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · first_quarter · Q1
Medicare reimbursement for physician, and hematology services, sickle cell disease and bone marrow transplants
HR 1409, Cancer Drug Coverage Parity Act
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410/S 2465 SCD Research, Surveillance Prevention and Treatment Act of 2017
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · first_quarter · Q1
Issues related to anti-epileptic drugs.
Healthcare issues related to the treatment of epilepsy.
Funding for epilepsy programs at CDC, HRSA, NIH
ALPHA-1 FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · first_quarter · Q1
CMS coverage policies - re: oxygen, Medicare reimbursement
H.R.3358/S.1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018 HR 1625, Consolidated Appropriations Act
FDA drug development and clinical trials; Precision Medicine Initiative; Patient Access to Care
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
ADULT CONGENITAL HEART ASSOCIATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · first_quarter · Q1
Congenital Heart Futures Act Reauthorization; HR 1222, S 477 Patient Access to Care
FY 18 Labor-HHS-Appropriations H.R.3358/S.1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018 HR 1625, Consolidated Appropriations Act
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · first_quarter · Q1
H.R. 1625 - Vehicle for Consolidated Appropriations Act 2018 FY 2019 Labor, Health and Human Services and Education Appropriations bill
H.R. 1409 Cancer Drug Parity Act of 2017 H.R. 4978 Chronic Disease Management Act of 2018
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · fourth_quarter · Q4
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410 SCD Research, Surveillance Prevention and Treatment Act of 2017
Medicare reimbursement for physician, and hematology services, sickle cell disease and bone marrow transplants
Labor-HHS-Education Appropriations Act for FY 2018, HR 3358, S 1771 Hematology research, prevention and public health programs Sickle Cell Disease Surveillance
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · fourth_quarter · Q4
Implementation of the Affordable Care Act
Reimbursement for healthcare services provided by epilepsy centers
Funding for epilepsy programs at CDC, HRSA, NIH
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · fourth_quarter · Q4
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
reimbursement for hemophilia services and treatments; Medicaid reimbursement for treatments for hemophilia patients
Implementation of the Affordable Care Act; HR 1628 American Health Care Act; HR 1628 Better Care Reconciliation Act and other legislation to Repeal & Replace Affordable Care Act.
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · fourth_quarter · Q4
Implementation of the Affordable Care Act HR 1628 American Health Care Act and other efforts to repeal and replace ACA. HR 1628 Better Care Reconciliation Act
Issues related to reimbursement for hemophilia services and treatments. Medicaid Outpatient Drug Rule; Medicare Part B Drug reimbursement
Issues related to the 340B drug discount program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · fourth_quarter · Q4
H.R.3358/S.1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018 H.R.3354 - Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018
Public Law 115-97 AN act to Provide for reconciliation pursuant to Title II and V of the concurrent resolution on the budget for fiscal year 2018 (tax reform)
ADULT CONGENITAL HEART ASSOCIATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · fourth_quarter · Q4
FY 18 Labor-HHS-Appropriations H.R.3358/S.1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018
Congenital Heart Futures Act Reauthorization; HR 1222, S 477 Patient Access to Care
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
ALPHA-1 FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · fourth_quarter · Q4
CMS coverage policies - re: oxygen, Medicare reimbursement
FDA drug development and clinical trials; Precision Medicine Initiative; American Health Care Act HR 1628, Patient Access to Care
H.R.3358/S.1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
ADULT CONGENITAL HEART ASSOCIATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · third_quarter · Q3
FY 18 Labor-HHS-Appropriations H.R.3358/S.1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018
Congenital Heart Futures Act Reauthorization; HR 1222, S 477 American Health Care Act, HR 1628 Better Care Reconciliation Act, HR 1628 Cassidy-Graham
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
ALPHA-1 FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · third_quarter · Q3
CMS coverage policies - re: oxygen, Medicare reimbursement
H.R.3358/S.1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018
FDA drug development and clinical trials; Precision Medicine Initiative; American Health Care Act HR 1628, Better Care Reconciliation Act HR 1628, Graham Cassidy
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · third_quarter · Q3
Implementation of the Affordable Care Act HR 1628 American Health Care Act and other efforts to repeal and replace ACA. HR 1628 Better Care Reconciliation Act
Issues related to reimbursement for hemophilia services and treatments. Medicaid Outpatient Drug Rule; Medicare Part B Drug reimbursement
Issues related to the 340B drug discount program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · third_quarter · Q3
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
Hemophilia research, prevention, surveillance and service programs and issues.
Implementation of the Affordable Care Act; HR 1628 American Health Care Act; HR 1628 Better Care Reconciliation Act and other legislation to Repeal & Replace Affordable Care Act.
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · third_quarter · Q3
Research and public health programs in epilepsy.
Implementation of the Affordable Care Act
Issues related to anti-epileptic drugs.
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · third_quarter · Q3
HR 1409, Cancer Drug Coverage Parity Act
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410 SCD Research, Surveillance Prevention and Treatment Act of 2017
Labor-HHS-Education Appropriations Act for FY 2018, HR 3358, S 1771 Hematology research, prevention and public health programs Sickle Cell Disease Surveillance
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · third_quarter · Q3
HR 2810/ S 1519, National Defense Authorization Act
H.R.3358/S.1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018 H.R.3354 - Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · second_quarter · Q2
Labor-HHS-Education Appropriations, FY 2017 and FY 2018 PL 114-223 Continuing Appropriations and Military Construction, Veteran's and related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
HR 2810/ S 1519, National Defense Authorization Act
ACA implementation; HR 1409 Cancer Drug Coverage Parity Act; HR 1313 Preserving Employee Wellness Programs Act; HR 1628 American Health Care Act; Better Care Reconciliation Act; HR 2999 Patients' Access to Treatment Act; S 1045 Save Women's Preventive Care Act; S 689 Invest in Women's Health Act
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · second_quarter · Q2
Reimbursement for healthcare services provided by epilepsy centers
Funding for epilepsy programs at CDC, HRSA, NIH
Issues related to anti-epileptic drugs.
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · second_quarter · Q2
Hemophilia research, prevention, surveillance and service programs and issues.
Implementation of the Affordable Care Act; HR 1628 American Health Care Act and other legislation to Repeal & Replace Affordable Care Act.
Labor-HHS-Appropriations Act for DY 2017 & 2018 Funding for Hemophilia programs
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · second_quarter · Q2
Issues related to the 340B drug discount program
Issues related to reimbursement for hemophilia services and treatments. Medicaid Outpatient Drug Rule; Medicare Part B Drug reimbursement
Implementation of the Affordable Care Act HR 1628 American Health Care Act and other efforts to repeal and replace ACA.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · second_quarter · Q2
Labor-HHS-Education Appropriations Act for FY 2017 & 2018 Hematology research, prevention and public health programs Sickle Cell Disease Surveillance
HR 1409, Cancer Drug Coverage Parity Act
Medicare reimbursement for physician, and hematology services, sickle cell disease and bone marrow transplants
ALPHA-1 FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · second_quarter · Q2
FDA drug development and clinical trials; Precision Medicine Initiative; American Health Care Act HR 1628, Better Care Reconciliation Act.
FY 17 Labor-HHS-Appropriations/FY 18 Labor-HHS-Appropriations
CMS coverage policies - re: oxygen, Medicare reimbursement
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
ADULT CONGENITAL HEART ASSOCIATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · second_quarter · Q2
FY 2017 Labor-HHS-Appropriations; FY 18 Labor-HHS-Appropriations
Congenital Heart Futures Act Reauthorization; HR 1222, S 477 American Health Care Act, HR 1628 Better Care Reconciliation Act
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
Issues related to anti-epileptic drugs.
Reimbursement for healthcare services provided by epilepsy centers
Funding for epilepsy programs at CDC, HRSA, NIH
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
Hemophilia research, prevention, surveillance and service programs and issues.
Labor-HHS-Appropriations Act for DY 2017 & 2018 Funding for Hemophilia programs
Implementation of the Affordable Care Act; HR 1628 American Health Care Act and other legislation to Repeal & Replace Affordable Care Act.
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
Issues related to reimbursement for hemophilia services and treatments. Medicaid Outpatient Drug Rule; Medicare Part B Drug reimbursement
Issues related to the 340B drug discount program
Implementation of the Affordable Care Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
HR 1409, Cancer Drug Coverage Parity Act
Labor-HHS-Education Appropriations Act for FY 2017 & 2018 Hematology research, prevention and public health programs
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease.
ADULT CONGENITAL HEART ASSOCIATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
FY 2017 Labor-HHS-Appropriations; FY 18 Labor-HHS-Appropriations
Congenital Heart Futures Act Reauthorization; HR 1222, S 477
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
ALPHA-1 FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
FY 17 Labor-HHS-Appropriations/FY 18 Labor-HHS-Appropriations
FDA drug development and clinical trials; 21st Century Cures/Innovations for Healthier Americans; Precision Medicine Initiative; Public Law No. 114-255
CMS coverage policies - re: oxygen, Medicare reimbursement
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
Biosimilars (FDA); ACA implementation; HR 2739/S 1566 - Cancer Drug Coverage Parity Act; HR 1313 Preserving Employee Wellness Programs Act; HR 1628 American Health Care Act
Labor-HHS-Education Appropriations, FY 2017 and FY 2018 PL 114-223 Continuing Appropriations and Military Construction, Veteran's and related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · fourth_quarter · Q4
Biosimilars - naming (FDA); precision medicine initiative; ACA implementation; clinical trials issues (FDA); HR 2739/S 1566 - Cancer Drug Coverage Parity Act
Labor-HHS-Education Appropriations, FY 2017 PL 114-223 Continuing Appropriations and Military Construction, Veteran's Affairs and related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALPHA-1 FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · fourth_quarter · Q4
CMS coverage policies - re: oxygen; Medicare reimbursement
FDA drug development and clinical trials; 21st Century Cures/Innovations for Healthier Americans; Precision Medicine Initiative
FY 17 Labor HHS
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
ADULT CONGENITAL HEART ASSOCIATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · fourth_quarter · Q4
FY 2017 Labor-HHS appropriations
Congenital Heart Futures Act Reauthorization; HR 3952, S 2248
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · fourth_quarter · Q4
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease. HR 1807, Sickle Cell Disease Research Surveillance Prevention and Treatment Act of 2015; Resolution on Sickle Cell Disease Trait
Departments of Labor, HHS, Education Appropriations Act for FY 2017, S.3040; no House bill number Hematology research, prevention and public health programs.
Medicare reimbursement for physician and hematology services
FY2021, Labor, HHS and Education Appropriations bill Funding for DOD breast cancer research program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Funding for epilepsy programs at CDC, HRSA, NIH
Reimbursement for healthcare services provided by epilepsy centers;
Implementation of the Affordable Care Act
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Hemophilia research, prevention, surveillance and service programs and issues
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients S.3233/HR5952 Hemophilia SNF Access Act. Medicare, Medicaid and other policy changes due to the COVID emergency. Medicare Coverage and Reimbursement of drugs Medicaid coverage policy S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Surprise medical billing
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Drug Pricing Issues S.3233/HR5952 Hemophilia SNF Access ActS.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare, Medicaid and other policy changes due to the COVID emergency
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Healthcare issues related to the treatment of epilepsy.
Implementation of the Affordable Care Act
Reimbursement for healthcare services provided by epilepsy centers; Medicare Physician Fee Schedule and Hospital Outpatient PPS 2020 Proposed Rules
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Funding for Hemophilia program FY 2020 Labor, HHS and Education Appropriations
Implementation of the Affordable Care Act S 1895, Lower Healthcare Cost Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Research in hematology
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
FY20 National Defense Authorization Act - CDMRP
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Reimbursement for healthcare services provided by epilepsy centers; modernizing PART D and Medicare Advantage Rule Medicare Physician Fee Schedule and Hospital Outpatient PPS 2020 Proposed Rules
Funding for epilepsy programs at CDC, HRSA, NIH
Research and public health programs in epilepsy.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Issues related to the 340B drug discount program and drug pricing policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lower Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 SJ Res 52; Public Charge
Funding for Hemophilia program FY 2020 Labor, HHS and Education Appropriations
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare Physician Fee Schedule for 2020 Proposed Rule
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Hemophilia program funding
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Reimbursement for healthcare services provided by epilepsy centers; modernizing PART D and Medicare Advantage Rule
Research and public health programs in epilepsy.
Implementation of the Affordable Care Act
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Hemophilia research, prevention, surveillance and service programs and issues
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lover Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
Hemophilia research, prevention, surveillance and service programs and issues
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Research and public health programs in epilepsy.
Funding for epilepsy programs at CDC, HRSA, NIH
Reimbursement for healthcare services provided by epilepsy centers; modernizing PART D and Medicare Advantage Rule
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Issues related to the 340B drug discount program and drug pricing policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Research in hematology
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
HR 1409, Cancer Drug Coverage Parity Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
reimbursement for hemophilia services and treatments; Medicaid reimbursement for treatments for hemophilia patients
Funding for Hemophilia programs
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Hemophilia program funding
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Research and public health programs in epilepsy.
Healthcare issues related to the treatment of epilepsy.
Reimbursement for healthcare services provided by epilepsy centers; modernizing PART D and Medicare Advantage Rule
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
H.R. 6157 Labor-HHS-Appropriations Act for FY 2019 Funding for Hemophilia programs
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Reimbursement for healthcare services provided by epilepsy centers
Funding for epilepsy programs at CDC, HRSA, NIH
Healthcare issues related to the treatment of epilepsy.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Labor-HHS-Education Appropriations Act 2019, HR 6157 Hemophilia program funding
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
HR 1409, Cancer Drug Coverage Parity Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
reimbursement for hemophilia services and treatments; Medicaid reimbursement for treatments for hemophilia patients
Implementation of the Affordable Care Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Reimbursement for healthcare services provided by epilepsy centers
Healthcare issues related to the treatment of epilepsy.
Implementation of the Affordable Care Act
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Implementation of the Affordable Care Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Labor-HHS-Education Appropriations Act for FY 2019 Hematology research, prevention and public health programs Sickle Cell Disease Surveillance
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Labor-HHS-Appropriations Act for FY 2019 Funding for Hemophilia programs
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Labor-HHS-Education Appropriations Act for FY 2019 Hematology research, prevention and public health programs Sickle Cell Disease Surveillance
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Research and public health programs in epilepsy.
Implementation of the Affordable Care Act
Reimbursement for healthcare services provided by epilepsy centers
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
HR 1409, Cancer Drug Coverage Parity Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Issues related to anti-epileptic drugs.
Research and public health programs in epilepsy.
Healthcare issues related to the treatment of epilepsy.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Labor-HHS-Appropriations Act for FY 2018, HR 3358/ S 1771 Funding for Hemophilia programs
Hemophilia research, prevention, surveillance and service programs and issues.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
HR 2810/ S 1519, National Defense Authorization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
reimbursement for hemophilia services and treatments; Medicaid reimbursement for treatments for hemophilia patients
Labor-HHS-Appropriations Act for FY 2018, HR 3358/ S 1771 Funding for Hemophilia programs
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Funding for epilepsy programs at CDC, HRSA, NIH
Healthcare issues related to the treatment of epilepsy.
Reimbursement for healthcare services provided by epilepsy centers
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Medicare reimbursement for physician, and hematology services, sickle cell disease and bone marrow transplants
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
ACA implementation; HR 1628 American Health Care Act; Better Care Reconciliation Act
tax reform
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Healthcare issues related to the treatment of epilepsy.
Implementation of the Affordable Care Act
Research and public health programs in epilepsy.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
reimbursement for hemophilia services and treatments; Medicaid reimbursement for treatments for hemophilia patients
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410 SCD Research, Surveillance Prevention and Treatment Act of 2017
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Research and public health programs in epilepsy.
Healthcare issues related to the treatment of epilepsy.
Implementation of the Affordable Care Act
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
reimbursement for hemophilia services and treatments; Medicaid reimbursement for treatments for hemophilia patients
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Medicare reimbursement for physician and hematology services
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
HR 1600, Patient Access to Treatment Act; HR 2739 Cancer Drug Coverage Parity Act/S. 1566 Cancer Drug Coverage Parity Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE